Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

{
  "main_header": {
    "sid": 1117543,
    "name": "Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.",
    "stock_name": "Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.",
    "full_name": "Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.",
    "name_url": "stocks-analysis/zhejiang-wolwo-bio-pharmaceutical-co-",
    "exchange": 46,
    "exchangecode": "SHE",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "27.71",
    "chg": -0.03,
    "chgp": "-0.11%",
    "dir": -1,
    "prev_price": "27.74",
    "mcapval": "13,375.08",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100001R58",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "9.25 M",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zhejiang-wolwo-bio-pharmaceutical-co--1117543-46&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Mixed Financial Results Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/mojo-premium/zhejiang-wolwo-bio-pharmaceutical-co-ltd-joins-momentum-now-strategy-for-potential-upside-3790972",
        "imagepath": "",
        "date": "2026-01-13 15:35:59",
        "description": "<p><strong>Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.</strong>, a prominent player in the pharmaceuticals and biotechnology sector, has recently reported its financial performance for the quarter ending March 2025. The results indicate a challenging period for the company, marked by negative financial outcomes.</p>\n\n<p>Despite the overall downturn, there are some noteworthy highlights in the financial metrics. The company experienced a significant decrease in raw material costs, which fell by 4.57% year-over-year. This reduction may provide some relief in terms of operational expenses, potentially aiding in future profitability.</p>\n\n<p>Furthermore, <strong>Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.</strong> reported its highest cash and equivalents position at CNY 2,601.1 MM. This strong liquidity position could offer the company flexibility in managing its operations and pursuing growth opportunities, e..."
      }
    ],
    "total": 1,
    "sid": "1117543",
    "stock_news_url": "https://www.marketsmojo.com/news/zhejiang-wolwo-bio-pharmaceutical-co--1117543"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Reports Mixed Financial Results Amid Market Challenges

2026-01-13 15:35:59

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a prominent player in the pharmaceuticals and biotechnology sector, has recently reported its financial performance for the quarter ending March 2025. The results indicate a challenging period for the company, marked by negative financial outcomes.

Despite the overall downturn, there are some noteworthy highlights in the financial metrics. The company experienced a significant decrease in raw material costs, which fell by 4.57% year-over-year. This reduction may provide some relief in terms of operational expenses, potentially aiding in future profitability.

Furthermore, Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. reported its highest cash and equivalents position at CNY 2,601.1 MM. This strong liquidity position could offer the company flexibility in managing its operations and pursuing growth opportunities, e...

Read full news article

View All News